Not only that but
MD - "...we expect a number of interested pharmaceutical companies to enter formal due diligence on ATL 1103 in the coming months"
This suggests there was a decent number of pharma's who wanted a piece of the action BEFORE the results and were waiting for results. Now their mouths will be watering at the opportunity to have this drug and so should ours at the prospect of seeing a massive multiplier effect on the sp in the coming months.
Licensing, page-2
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
-0.006(5.71%) |
Mkt cap ! $89.25M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.9¢ | $35.68K | 354.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 196446 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 238249 | 4 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |